Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The color(s) blue gray and red is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of The word ZEPOSIA in dark blue with a triangle design in gray blue and red to the left.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
550 x 425
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Celgene Corporation
*STREET
86 Morris Avenue
*CITY
Summit
*STATE
(Required for U.S. applicants)
New Jersey
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
07901
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer,
multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the
immune system
FILING BASIS
SECTION 1(b)
FILING BASIS
SECTION 44(d)
FOREIGN APPLICATION NUMBER
UK00003445154
FOREIGN APPLICATION
COUNTRY
United Kingdom
FOREIGN FILING DATE
11/18/2019
INTENT TO
PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT
Attached is the foreign application in support of the priority claim.
Melanie A. Miller, J. Trevor Cloak, Chanel L. Lattimer, Brianne L. Polito, Ashley Kessler, Mayura Noordyke, Kevin Gibbs
CORRESPONDENCE INFORMATION
NAME
Camille M. Miller
FIRM NAME
Cozen O'Connor
INTERNAL ADDRESS
Suite 2800
STREET
1650 Market Street
CITY
Philadelphia
STATE
Pennsylvania
COUNTRY
United States
ZIP/POSTAL CODE
19103
PHONE
215-665-7273
FAX
2157012273
*EMAIL ADDRESS
cmiller@cozen.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
275
*TOTAL FEE PAID
275
SIGNATURE INFORMATION
SIGNATURE
/Camille M. Miller/
SIGNATORY'S NAME
Camille M. Miller
SIGNATORY'S POSITION
attorney
SIGNATORY'S PHONE NUMBER
215-665-7273
DATE SIGNED
11/18/2019
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88696906
Filing Date:11/18/2019
To the Commissioner for Trademarks:
MARK: ZEPOSIA (stylized and/or with design, see mark)
The literal element of the mark consists of ZEPOSIA. The color(s) blue gray and red is/are claimed as a feature of the mark. The mark consists of The word ZEPOSIA in dark blue with a triangle design
in gray blue and red to the left.
The applicant, Celgene Corporation, a corporation of Delaware, having an address of
86 Morris Avenue
Summit, New Jersey 07901
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative
colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on United Kingdom application number UK00003445154, filed 11/18/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
Miscellaneous Statement
Attached is the foreign application in support of the priority claim.
The applicant hereby appoints Camille M. Miller. Other appointed attorneys are Melanie A. Miller, J. Trevor Cloak, Chanel L. Lattimer, Brianne L. Polito, Ashley Kessler, Mayura Noordyke, Kevin
Gibbs. Camille M. Miller of Cozen O'Connor, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
Suite 2800
1650 Market Street
Philadelphia, Pennsylvania 19103
United States
215-665-7273(phone)
2157012273(fax)
cmiller@cozen.com (authorized).
The attorney docket/reference number is CELG-2069US/.
Camille M. Miller submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Camille M. Miller
Cozen O'Connor
Suite 2800
1650 Market Street
Philadelphia, Pennsylvania 19103
215-665-7273(phone)
2157012273(fax)
cmiller@cozen.com (authorized).
Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the
email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Camille M. Miller/ Date: 11/18/2019
Signatory's Name: Camille M. Miller
Signatory's Position: attorney
Payment Sale Number: 88696906
Payment Accounting Date: 11/18/2019
Serial Number: 88696906
Internet Transmission Date: Mon Nov 18 17:58:00 EST 2019
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2019111817580096
3691-88696906-7005d531f57b8cea18abd99b8b
47deba04c50e249131d427d3c0c8d088dfbc2a-C
C-57595286-20191118174448568865